sVNTs are specifically designed to quantify the antibody-mediated blocking of the first step of virus infection, i.e., the initial binding of the viral RBD to the human receptor ACE2, resulting in a high-grade correlation with titers of nAbs quantified by live-virus NTs (9). This evidence concerns the gene ACE2 and viral infectious disease.